Big news today – we closed a $35M financing w/ Lux Capital, Pivotal Bioventures, The Column Group, DCVC and other outstanding investors to help us advance our pipeline of novel protein degraders. We’re also thrilled to welcome Mike Grey as Chairman! prn.to/39QkchL

Synthetic biology investments broke records in 2020 despite a global pandemic, an economic recession and the highest levels of unemployment since the Great Depression. #WeMakeDNA #ScienceDoesntStop SynBioBeta bit.ly/3aiflq0

[FR] Pour la deuxième année consécutive, DNA Script est sélectionnée dans le #FrenchTech120. C'est une reconnaissance dont nous sommes très fiers, après une année 2020 marquée par une levée de fonds de 46M€ et le lancement du programme d'évaluation de notre premier produit. 1/2

The original forecast we did for AI training landed at $1 billion to train the largest model by 2025. But it seemed so crazy that we plotted a range and landed at $100m. Nvidia's Bryan Catanzaro Bryan Catanzaro's just said he could see $1B models by 2025. Lesson: follow your conviction.

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand dnascript.com/press-releases…

We're collaborating with GE HealthCare for on-demand vaccines/therapeutics in response to biothreats for the DARPA NOW project. This is our 2nd partnership, after the French Direction générale de l'armement 🇫🇷, to develop a rapid response platform to combat emerging biothreats! bit.ly/DNAS_GE_DARPA

Good analysis of future for DNA Script in #synbio

GenomeWeb - great article on #DNAonDemand! genomeweb.com/business-news/…

@TrinityResInnov -invented material shows fastest magnetic switching ever recorded siliconrepublic.com/innovation/mag… via Silicon Republic

Today is a very exciting day for the team here at Ginkgo Bioworks. Our mission has always been to make biology easier to engineer. This announcement marks the beginning of a new chapter in our journey to realize our vision for synthetic biology. bloomberg.com/news/articles/…

Just announced: the launch of our #SYNTAX System, the 1st benchtop nucleic acid printer powered by #enzymaticDNAsynthesis! With this launch, we're accelerating molbio applications, genomic workflows & #lifescience discoveries. ow.ly/l22m50FaApL #synbio #DNAonDemand

I’m very proud to announce the launch of our first product featuring Enzymatic DNA Synthesis : the SYNTAX system 🧬 🚀 Thanks to our awesome team to make this possible! #DNA

Wall Street wins signal the start of a synthetic biology revolution pitchbook.com/news/articles/… via PitchBook News

Happy to support the The Long Run biotech podcast. Luke Timmerman features in-depth, insightful conversations with biotech leaders. Worth a listen! Timmerman Report #biotech #podcast #biotechnology #lifescience ow.ly/fkaL50FzYmw

We've been named a Top 100 Healthcare Technology Company by The Healthcare Technology Report! We're honored to be recognized among other incredible #biotech companies & are excited to see the disruptive changes our #EDS technology will bring. #synbio #DNA ow.ly/MFDz50FXbTJ